Multidrug-Resistant Tuberculosis Treatment Outcomes in Karakalpakstan, Uzbekistan: Treatment Complexity and XDR-TB Among Treatment Failures

PLoS ONE - United States
doi 10.1371/journal.pone.0001126
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Public Library of Science (PLoS)

Related search

Pre-Extensively Drug Resistant Tuberculosis (Pre-XDR-Tb) Among Pulmonary Multidrug Resistant Tuberculosis (MDR-TB) Patients in Bangladesh

Journal of Tuberculosis Research
2018English

Hypokalemia Among Patients Receiving Treatment for Multidrug-Resistant Tuberculosis

Chest
CardiologyCritical CareCardiovascular MedicineIntensive Care MedicinePulmonaryRespiratory Medicine
2004English

Safety and Efficacy of Delamanid in the Treatment of Multidrug-Resistant Tuberculosis (MDR-TB)

Clinical Medicine Insights: Therapeutics
MedicinePharmacologyPharmaceutical Science
2013English

Pyrido[1,2-A]benzimidazole-Based Agents Active Against Tuberculosis (TB), Multidrug-Resistant (MDR) TB and Extensively Drug-Resistant (XDR) TB

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2011English

Treatment Outcomes of Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2009English

Revolutionary New Treatment Regimens for Multidrug-Resistant Tuberculosis

The Lancet Infectious Diseases
Infectious Diseases
2019English

Clofazimine for the Treatment of Multidrug-Resistant Tuberculosis

Clinical Microbiology and Infection
MedicineInfectious DiseasesMicrobiology
2019English

Reducing Harm in the Treatment of Multidrug-Resistant Tuberculosis

The Lancet
Medicine
2018English

Treatment Outcomes of Rifabutin-Containing Regimens for Rifabutin-Sensitive Multidrug-Resistant Pulmonary Tuberculosis

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy